Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Guardant Health
MedTech
Guardant wins FDA nod for test guiding AstraZeneca’s Etcamah
Hot on the heels of the approval of AZ's breast cancer drug Etcamah, Guardant Health has been given the green light for its companion diagnostic.
Ben Adams
Sep 7, 2026 2:08am
Guardant taps Patrick Dempsey for colorectal cancer awareness
Jul 28, 2026 8:54am
Guardant Health nabs FDA test approval for BI's new cancer drug
Jun 12, 2026 9:47am
Nuvalent teams up with Guardant Health for companion diagnostics
May 4, 2026 2:48am
Guardant hits the road with colon cancer blood test
Mar 5, 2026 5:50am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
